This topic contains a solution. Click here to go to the answer

Author Question: Which of the following age-related factors that may impact dosing are shared by both pediatric and ... (Read 25 times)

ENagel

  • Hero Member
  • *****
  • Posts: 540
Which of the following age-related factors that may impact dosing are shared by both pediatric and
  geriatric patients?
 
  A. lower pH of stomach
  B. thinner skin
  C. decreased kidney function
  D. increased circulation

Question 2

Joel weighs 65 kg. Converted to pounds Joel weighs _________. (Use either proportion or dimensional
  analysis)
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blazinlyss

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

B

Answer to Question 2

143 lb




ENagel

  • Member
  • Posts: 540
Reply 2 on: Jul 3, 2018
Great answer, keep it coming :)


parker125

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library